flavus RC2053, RC2054, RC2055, RC2056, RC2057, RC2058, RC2059, RC

flavus RC2053, RC2054, RC2055, RC2056, RC2057, RC2058, RC2059, RC2060, RC2061, A. parasiticus RC2062). All isolates were used in qualitative

experiments and only the most 3-MA in vivo potent AFB1 producers were used in growth studies (A. flavus RC2053, RC2054, RC2055, RC2056). The isolates were maintained at 4 °C on malt extract agar (MEA) slants and at −80 °C in 15% glycerol. The effect of lactobacilli strains on A. flavus strains was detected by two qualitative methods: Lactobacillus rhamnosus L60 and L. fermentum L23 strains were assayed for inhibition of 10 A. flavus strains. The agar overlay method was used with some modifications (Magnusson & Schnürer, 2001). MRS agar plates on which L. rhamnosus L60 and L. fermentum L23 were inoculated in 2-cm-wide lines each and incubated at 37 °C under a 5% CO2 atmosphere for 48 h. After the incubation period, the plates were overlaid with a soft agar (75% by weight agar) preparation of MEA containing 9.5 × 102 fungal spores mL−1, determined by counting on a Neubauer haemocytometer. The plates were incubated this website aerobically at 25 °C for 5 days. The zones of inhibition of Aspergillus were estimated using a semiquantitative scale: (−), lack of Aspergillus growth inhibition over Lactobacillus culture; (+/−),

minimal inhibition of Aspergillus growth over Lactobacillus culture; (+), partial inhibition of Aspergillus growth over Lactobacillus culture; (++), total inhibition of Aspergillus growth over Lactobacillus culture. Plates containing only the fungal spore inoculums (without Lactobacillus strains) were used as a control. Lactobacillus L60 and L23 strains were seeded until covering one-third of the surface of MRS agar plates and incubated in optimal conditions at 37 °C for 48 h. An MEA agar plug with A. flavus was placed on the centre of the free surface of these MRS agar plates and incubated aerobically at

25 °C for 5 days in the dark. Lactobacillus rhamnosus L60 and L. fermentum L23 suspensions Liothyronine Sodium were prepared in MRS broth (bioMérieux) (Rogosa & Sharpe, 1963) and adjusted to 0.5 of the McFarland scale, corresponding to final concentration of 1.5 × 108 CFU mL−1. An aliquot of 1 mL from each lactobacillus suspension was placed into sterile Petri dishes. MRS agar (bioMérieux) (Rogosa & Sharpe, 1963) was poured into Petri dishes and stirred to homogenize the content. The plates were inoculated in the centre with a suspension of fungal spores from 7-day-old cultures on MEA in semisolid agar. The plates were incubated at 25 °C and the colony radius was measured daily. For each colony, two radii, measured at right angles to one another, were averaged to find the mean radius for that colony. All colony radii were determined by using three replicates for each tested fungus. The radial growth rate (mm day−1) was subsequently calculated by linear regression of the linear phase of growth and the time at which the line intercepted the x-axis was used to calculate the lag phase.

Posted in Antibody | Leave a comment

4, containing DNAse (10 μg mL−1), 4 mM phenylmethylsulfonyl fluor

4, containing DNAse (10 μg mL−1), 4 mM phenylmethylsulfonyl fluoride and 5 mg of lysozyme and incubated for 30 min at 37 °C. Cells were disrupted on ice by sonification (35 W power for 10 min with 0.5-s pulses). Unbroken cell and cell debris were removed by centrifugation for 45 min at 10 000 g at 4 °C, and the supernatant was used as the crude cell extract. Membrane fractions were prepared by ultracentrifugation at 145 000 g for 2 h at 4 °C. The membrane pellet was resuspended directly in 50 mM 3-(N-morpholino)propane sulfonate, pH 7.0, buffer. The protein concentration of the subcellular fractions was determined (Lowry

et al., 1951) with bovine serum albumin as the standard. For overproduction of FocAStrep–N, cultures of E. coli BL21 containing pASK-IBA5focA were grown aerobically at 37 °C in 4 L of TB medium supplemented with Antidiabetic Compound Library solubility dmso 100 μg ampicillinmL−1 to an OD600 nm of approximately 0.5. Gene expression was induced by addition of 0.2 μg mL−1

anhydrotetracycline and cultures were incubated at 16 °C with continuous shaking for 14 h. Cells were harvested by centrifugation at 8000 g for 25 min and 4 °C. Cell Afatinib pellets were resuspended in 15 mL of buffer (50 mM Tris/HCl, 170 mM NaCl, pH 8.0) and were disrupted by sonification (35 W power for 10 min with 0.5-s pulses). The cell lysate was centrifuged for 30 min at 19 000 g at 4 °C. The resulting crude extract was again

centrifuged for 60 min at 100 000 g at 4 °C and the membrane fraction was resuspended in 5 mL buffer W (100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 8.0). The protein concentration was determined and 3 mg of n-dodecyl-β-maltoside (DDM) (Glycon Biochemicals, Luckenwalde, Germany) was added per milligram of protein under stirring and incubated at 4 °C overnight. The solution was centrifuged for 60 min at 100 000 g and 4 °C. The resulting supernatant containing solubilized Strep-tagged FocA was loaded onto a 5-mL column containing a Strep-Tactin-Sepharose (IBA, Göttingen) matrix. Further purification steps were carried out exactly as described in the IBA standard protocol under aerobic conditions at 4 °C (Schmidt & Skerra, 2007). The yield of FocAStrep–N was generally 1 mg L−1 of culture. Aliquots of 50-μg protein Selleck Ixazomib from crude extracts were separated on 10% w/v sodium dodecyl sulfate (SDS)-PAGE (Laemmli, 1970) and transferred to nitrocellulose membranes as described (Towbin et al., 1979.). Polyclonal antibodies raised against a FocA peptide (amino acids 141–159; Seqlab, Göttingen, Germany) were affinity purified after coupling of purified FocA to AminoLink® coupling gel (Pierce, Rockford, IL) exactly as described by the manufacturer. Elution of the bound antibodies was achieved using 50 mM glycine-HCl, pH 2.5, 0.1% w/v Triton X-100 and 0.15 M NaCl.

Posted in Antibody | Leave a comment

Hepatitis B Which ARV regimen should be recommended? Should this

Hepatitis B Which ARV regimen should be recommended? Should this be continued after delivery? What is the preferred mode of delivery for women with HBV coinfection? Should see more all infants born to hepatitis B coinfected mothers receive (a) hepatitis B vaccination; (b) hepatitis B immune globulin? Should pregnant women with HBV be vaccinated against HAV? Hepatitis C Which ARV regimen should be recommended? Should this be continued after delivery? What is the preferred mode of delivery

for women with HCV coinfection? Should pregnant women ZD1839 with HCV be vaccinated against HBV and HAV? Is there a place for treating hepatitis C in pregnancy to prevent MTCT of hepatitis C? Should these women be monitored in any additional way compared to those not coinfected? Should the HCV be treated? Study design: SRs, RCTs, observational, risk, economic Population: HIV-positive women Intervention: obstetric delivery and fetal monitoring Comparator: none Outcomes: death, AIDS, non-AIDS

co-morbidities, maternal obstetric morbidity, infant mortality and morbidity, mother-to-child HIV transmission, drug resistance Mode of delivery At what level would a HIV viral load be ‘safe’ for vaginal delivery? When should a CS be performed?

What ART should be given during delivery Obstetric procedures When should VBAC be regarded as ‘safe’? Is it safe to perform ECV, induction of labour, instrumental delivery, episiotomy in HIV-positive SPTLC1 pregnant women? What fetal monitoring tests should be performed during delivery? Trisomy/anomaly screening tests, amniocentesis and chorionic villus sampling Which tests are most appropriate for use in HIV-positive women? What should be the ARV management of a woman requiring amniocentesis or chorionic villus sampling who is not yet on ART Ruptured membranes What is the optimum ART and obstetric management for women presenting with both term and preterm ROMs? Study design: SRs, RCTs, observational, risk, economic Population: HIV-exposed infants Intervention: ART and prophylaxis for neonates Comparator: none Outcomes: death, AIDS, non AIDS co-morbidities, infant mortality and morbidity, mother-to-child HIV transmission, drug resistance.

Posted in Antibody | Leave a comment

30) to form a single-beam optical trap A R glutinis cell in the

30) to form a single-beam optical trap. A R. glutinis cell in the phosphate-buffered

saline (PBS) was trapped about 10 μm above the bottom of cover slip with a gradient force generated by the focused beam. The same laser beam was used to excite Raman scattering from molecules inside the trapped cell. The spectrum was obtained by a liquid-nitrogen-cooled charge-coupled detector. The spectral resolution of our Raman system was about 6 cm−1. The Raman measurement of an individual cell was performed with a 10-s exposure time and 30 mW excitation power. The Raman spectra of 100 cells were collected for each time point. The PBS background spectrum was recorded with the same acquisition condition without the trapped cells and subtracted from the Ion Channel Ligand Library ic50 spectra of individual cells. The subtracted spectra were then smoothed using the Adjacent-Averaging filter method. Preprocessing of spectral data was performed using matlab 7.0 software. The total carotenoid level in an individual cell was estimated from the peak intensity at 1509 cm−1 in its Raman spectrum. β-Carotene standard (purchased from Sigma-Aldrich) was dissolved in chloroform and diluted into a series of concentrations: 62.5, 125, 187.5, 250, 312.5, 375, 437.5, and 500 mg L−1. For each measurement, a 150-μL aliquot of β-carotene solution was added to the sealed holder and its

Raman spectrum was acquired with the same experimental parameters used for determining the cell spectra. The Raman spectrum of the pure chloroform was taken as background and subtracted from the above-mentioned spectra. A standard curve Selleck Ku 0059436 for carotenoid

quantification was linearly fitted by correlating the β-carotene concentration tetracosactide with the peak intensity at 1518 cm−1 in its Raman spectrum. Carotenoids are a family of isoprenoids containing a characteristic polyene chain of conjugated double bonds. In R. glutinis cells, carotenoid pigments predominantly consist of β-carotene, torulene, and torularhodin (Sakaki et al., 2002). In this work, the Raman spectra of R. glutinis cells cultivated for 12 and 32 h, as well as the pure β-carotene standard were acquired in order to verify the existence of carotenoids in the investigated stain (Fig. 1). The three fundamental carotenoid bands at 1505–1520 cm−1 assigned to C=C (ν1) in-phase stretching, 1156 cm−1 assigned to C–C (ν2) stretching and 1005 cm−1 assigned to δ(C=CH) in-plane rocking modes of CH3 groups were clearly visible in all of the spectra. Thus, to a high degree of certainty, these peaks resulted from carotenoid compounds. The intensity of these peaks for R. glutinis cells cultivated for 32 h was more than 30 times higher than those for cells cultivated for just 12 h. It is noteworthy that the C=C (ν1) peak was at 1509 cm−1 for carotenoids present in cells, while it was at 1518 cm−1 for the β-carotene standard. This difference may be attributed to the fact that carotenoids usually bind to proteins or lipids in R.

Posted in Antibody | Leave a comment

02%) Both gender

and height were strongly correlated wit

02%). Both gender

and height were strongly correlated with ENFD; however, when both were included in the model, height remained significant whereas gender was not significant at an alpha level of 0.10. A partial F-test on the additional effect of gender confirmed that gender could be dropped from the model. To examine the incremental effect of OXPHOS CI and CIV enzyme activity as well as of mt 8-oxo-dG levels, each was introduced individually into the previously constructed model. The association between distal leg ENFD and log PBMC CIV activity was significant (P = 0.04; incremental adjusted R 2 = 2%); that between distal leg ENFD and log PBMC CI activity was on the border of significance (P = 0.06; incremental adjusted R 2 = 1.58%). No significant NVP-BEZ235 in vivo association was observed

between distal leg ENFD and PBMC mt 8-oxo-dG. BMI was included in the adjusted model for distal leg ENFD because of its confounding effect on the relationship between ENFD and HIV RNA. The final model revealed that age, CD4 cell count, height, BMI, and log10 PBMCCIV activity were significant predictors of distal leg ENFD (adjusted R 2 = 27.33%; Table 3). Similar analyses were performed to construct a final regression model for proximal thigh ENFD. Although Pearson correlation showed potential associations of proximal thigh ENFD with height and CD4 cell count, a model with all

effects of interests (age, height, CD4 cell count, and log10HIV RNA) showed that only CD4 cell count was a significant predictor, explaining Talazoparib supplier approximately 4.6% of the variability in proximal thigh ENFD. Our study found that older age, larger BMI, taller stature, lower CD4 cell count and higher PBMC OXPHOS CIV levels were risk factors for lower distal leg ENFD in ARV-naïve Thai subjects free of neuropathy. ENFD documents the extent of damage present in unmyelinated nerve fibres per mm length of epidermis. A distal ENFD of 10 fibres/mm or less in US HIV-infected individuals with either no neuropathy or asymptomatic disease has been reported to confer a 14-fold greater risk of Amine dehydrogenase developing symptomatic disease than ENFD > 10 fibres/mm [8]. Early data obtained from hospitalized patients in the US before ARV medications were available indicated that approximately one-third of HIV-infected patients had both clinical and electrophysiological evidence of neuropathy [9]. Neuropathy was primarily noted to be a complication of late-stage HIV disease associated with advanced immunosuppression [10]. However, while neuropathic symptoms frequently did not occur until the development of AIDS, electrophysiological evidence of peripheral nerve involvement was found in many patients with normal or near-normal CD4 cell counts [11].

Posted in Antibody | Leave a comment

In this analysis, eight countries were classified at the initiati

In this analysis, eight countries were classified at the initiation interval (Brazil,[8] China,[9] Cuba,[7] Hungary,[10] India,[11] Ireland,[12] Norway,[13] and Philippines[14]); eight countries at the acceleration interval (Argentina,[15] Chile,[16] Greece,[17] New Zealand,[18] Panama,[19] Spain,[20] Thailand,[21] and UK[22]); and six countries at the peak-transmission interval (Australia,[23]

Canada,[24] Dominican Republic,[25, 26] Indonesia,[27] Mexico,[28] and the United States[29]). Chi-square or Fisher’s exact test was used as appropriate (SAS v9.2). Analysis of variance (anova) was used to assess the association between pandemic interval[5] in the exposure country and the identification of sentinel travelers with H1N1pdm09. A p selleck inhibitor value of <0.05 was considered statistically significant. An increase in the number of unspecified respiratory illnesses reported in GeoSentinel was observed during Epigenetic inhibitor nmr the early 2009 pandemic compared with data on respiratory illness reported from the same period in 2008 (Figure 2). Distribution of our laboratory-confirmed H1N1pdm09 cases coincided with the peak of respiratory illnesses documented from the week of April 26, 2009, through the end of June 2009.[7] Among the 203 (189 confirmed; 14 probable) H1N1pdm09

case-travelers identified, 56% were male; a majority, 60%, traveled for tourism; 20% traveled for business; and 86% were 10 to 44 years of age (Table 1). We compared H1N1pdm09 case-travelers with travelers in the GeoSentinel database with non-H1N1pdm09 unspecified respiratory illnesses or with nonrespiratory

Forskolin illnesses during the same period. Overall, the age profile of the three groups was significantly different (p < 0.0001; χ2). Paralleling age profiles in population-based studies[30] only 13% of our H1N1pdm09 case-travelers were older than 45 years, while 32% of our travelers with non-H1N1pdm09 unspecified respiratory illnesses and 29% of our travelers with nonrespiratory illnesses were in the above 45 years cohort. A higher proportion of H1N1pdm09 case-travelers were hospitalized (75%) compared with those with non-H1N1pdm09 unspecified respiratory illnesses (40%) and those with non-respiratory illnesses (13%) (p < 0.0001; χ2). H1N1pdm09 case-travelers self-declared having sought pre-travel medical advice from a medical provider less often (8%) than travelers with non-H1N1pdm09 unspecified respiratory illnesses (24%), and less often than travelers with nonrespiratory illnesses (43%) (p < 0.0001; χ2). Month-by-month clinic visit dates for 187 case-travelers were ascertained for 22 exposure countries (Table 2); 92% occurred from May to July 2009. The United States was the most frequently identified exposure countries (starting in May 2009), followed by Australia, the Philippines, UK, and Thailand.

Posted in Antibody | Leave a comment

Scaffolding is a normal process that exists across the lifespan a

Scaffolding is a normal process that exists across the lifespan and involves the use and development of complementary, alternative neural circuits to achieve a particular cognitive goal. Though introduced in the context of the preservation of cognitive abilities in aging, many of these phenomena also characterize the neurofunctional reorganization that sustains recovery after a brain

lesion (e.g. Marcotte et al., 2012), as well PD-332991 as the brain’s ability to cope with increasing complexity (Ansado et al., 2012, 2013). This convergence of phenomena could indicate that the mechanisms engaged to sustain cognitive abilities in aging are only one specific exemplar of more general neurofunctional mechanisms. Human communication relies on a set of linguistic abilities that themselves rely on an array of basic cognitive abilities that are widely spread over many areas of both hemispheres (Gernsbacher & Kaschak, 2003). As such, language abilities undoubtedly depend on a large array of neural networks that are broadly distributed selleck compound over the whole brain. At the same time, language abilities are among those that are best preserved in normal aging (Schaie & Willis, 1993). In the view of Wingfield & Grossman (2006), neurofunctional reorganization accounts for the relative preservation

of receptive language abilities with age. Thus, language abilities are particularly well suited to look for possible neurofunctional reorganization that could support cognitive preservation with

aging. Exploring the neural bases of a specific language component, syntactic processing, Tyler et al. (2010) conducted one study which supported the idea that bilateral recruitment of frontotemporal network helps older adults to improve their performance. However, this compensatory mechanism could well be task-dependent more than process-dependent. In order to provide a more comprehensive view of the phenomena underlying the preservation of language in aging one has to look at many other language components. Among all components of language, the semantic processing of words is the one that is best preserved in aging. It is also a component language that relies on the most widely distributed neural networks in both hemispheres. As such, tuclazepam it represents a unique window on the neurofunctional reorganization occurring in the aging brain. Our group undertook a series of studies to describe the neurofunctional reorganization underlying the preserved ability to process words’ semantics that is associated with optimal cognitive aging. These studies were conducted in order to examine whether the neurofunctional reorganization pattern underlying the preservation of the semantic processing of words corresponded to one or more of the phenomena already reported in the first section of this article. The following section summarizes these studies.

Posted in Antibody | Leave a comment

Here, we identified four β-lactamase genes, three of which were a

Here, we identified four β-lactamase genes, three of which were assigned to Class A β-lactamase, and one to Class D; no genes belonging to Classes B (metallo β-lactamases) and Class C were found (Supporting Information Fig. S1). We cannot conclude from these results that there are no Class B or Cyclopamine manufacturer C β-lactamases presented in our gut; further efforts should be made to delineate the whole profile of β-lactamase genes in human gut. The eight d-alanine-d-alanine ligase genes encoding resistance to d-cycloserine were assigned separately to two distinct groups

in the phylogenetic tree but the genes in each group are very close to each other, which suggested that the d-cycloserine resistance genes we identified were probably derived from phylogenetically closely linked gut bacteria of two major taxa (Fig. S2). Four bifunctional proteins with both domains involved in resistance to aminoglycoside Doramapimod antibiotics have been reported previously (Ferretti et al., 1986; Centron & Roy, 2002; Dubois et al., 2002; Mendes et al., 2004). In all cases, these bifunctional proteins had expanded substrate specificity. Pathogenic bacteria with these proteins would have a selective advantage in a clinical environment. Recently,

the kanamycin-resistance protein Kan4, which has an AAC(6′) domain fused to an acetyltransferase domain, was identified from soil using functional metagenomics. Functional analysis showed that only the AAC(6′) domain conferred kanamycin resistance (Donato et al., 2010). In this study, we used a functional metagenomic method to characterize ARGs in human gut microbiota. A novel kanamycin-resistance protein with an AAC(6′) domain fused to a hypothetical protein domain was identified. The kanamycin resistance of the N-terminal domain of this novel protein was confirmed, but the function of the C-terminus was unknown. According to conserved domain searching

through VAV2 NCBI, the C-terminus just matched a domain of unknown function (DUF2007). Therefore, whether the C-terminus of this protein correlated to substrate specificity or others was unclear, and its exact function needs to be further investigated. In our screen for tetracycline resistance, three known ribosomal protection-type genes were obtained: tet(O), tet(W), and tet(32). A tetracycline efflux gene tet(40) was also found in the same clone as tet(O). In a previous study using microarray analysis, tet(O) and tet(W) were the most prevalent tetracycline-resistance genes in fecal samples from adults from six European countries (Seville et al., 2009). In another study, numerous tet(W) sequences were uncovered through a functional metagenomic screen of antibiotic resistance in gut bacteria from two adult individuals in the USA (Sommer et al., 2009). The tetracycline efflux gene tet(40) was first identified in a human bacterial isolate and in a human gut metagenomic library. In both cases, it was linked to the mosaic tet(O/32/O) (Kazimierczak et al., 2008).

Posted in Antibody | Leave a comment

The mutagenesis was carried out with QuickChangeII Site-Directed

The mutagenesis was carried out with QuickChangeII Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). To construct the gene encoding the histidine-tagged MexT, mexT was amplified by PCR using the primers Nde-T1 and Xho-T2 (Table 2). The PCR products were treated with NdeI and XhoI, and inserted into pET-21a(+) (Novagen, Madison, WI) carrying a hexahistidine gene to be attached to the end of the target protein gene, yielding pET21a-MexT-(His)6.

Escherichia coli Origami(DE3)(pLysS) cells were transformed with pET21a-MexT-(His)6. To obtain the MexT-(His)6 recombinant protein, the cells were grown at 37 °C in 500 mL of LB broth, and 0.5 mM IPTG was added. The flask was shaken for an additional 24 h at 22 °C, and the MexT-(His)6 protein was purified from cell-free extracts by chromatography with a column of Profinity IMAC NVP-BKM120 cell line Ni-Charged Resin according to the manufacturer’s instructions (Bio-Rad). The MexT protein purified by this method appeared electrophoretically homogeneous. The 230-bp mexT-mexE intergenic DNA was amplified by PCR using AlexaFluor488-labeled primers pME4510-1Alexa and pME4510-2Alexa (Table 2). The PCR products were isolated from an agarose gel using the QIAquick Gel Extraction kit (Qiagen, GmbH, Hilden, Germany). A 20 μL volume of the reaction mixture containing 230 bp of labeled probe DNA (50 nM) and an appropriate

amount of homogeneously purified MexT-(His)6 was incubated http://www.selleckchem.com/products/Roscovitine.html for 20 min at 24 °C. An aliquot (10 μL) of the mixture was subjected to electrophoresis in 5% polyacrylamide gels (in 0.5 × TBE) at 50 V and 4 °C. The PAK6 results were analyzed with an image analyzer, LAS-4000miniEPUV (Fuji Photo Film Co., Tokyo,

Japan). The transcriptional start-point of the mexEF-oprN operon was determined according to the protocol for a 5′ rapid amplification of cDNA ends (5′ RACE) system (version 2) (Invitrogen, Carlsbad, CA). The total bacterial RNA for 5′ RACE was isolated from stationary phase cells of P. aeruginosa PAO1SC grown in LB broth using the Qiagen RNeasy minikit and RNase-free DNase (Promega), according to the manufacturer’s instructions. A mexE-specific primer (5′-CCGGTGAATTCGTCCCACTCG-3′), purified total RNA, and reverse transcriptase were used for the first-strand cDNA synthesis. A homopolymeric tail was then added to the 3′-end of the cDNA by terminal deoxynucleotidyl transferase (TdT) and dCTP. PCR amplification was performed using poly(C)-tailed cDNA as a template, the abridged anchor primer supplied by the manufacturer, and nested gene-specific primer1 (5′-CGTTCAGCGGTTGTTCGATGAC-3′). The PCR products were amplified again using nested gene-specific primer2 (5′-TGGAATTCCATGCCTTGGGTGGTTTCCG-3′) and the abridged universal amplification primer supplied by the manufacturer.

Posted in Antibody | Leave a comment

The 700-bp downstream region of uvrABbu was amplified using prime

The 700-bp downstream region of uvrABbu was amplified using primers 12.2 and 12.1 (nt 891827–892526). The kanamycin www.selleckchem.com/screening/protease-inhibitor-library.html resistance gene aph(3′)-IIIa from Enterococcus faecalis was amplified with its own promoter and stop codon from pBLS500 using primers III and IV (Shevchuk et al., 2004). Parameters for PCR reactions were denaturation at 94 °C for 2 min, 32 cycles of 94 °C for 15 s, 56 °C for 20 s, 68 °C for 2 min, and a final extension at 68 °C for 5 min. PCR fragments were fused by long PCR (Shevchuk et al., 2004), and the final 2279-kb PCR product containing

the uvrABbu gene with a kanamycin resistance gene insertion was cloned into pGEM-T (Promega), a vector that cannot replicate in B. burgdorferi, to yield pBL12. Selection and maintenance of E. coli DH5α transformants with pBL12 was performed using solid and liquid Luria–Bertani medium containing 100 μg mL−1 of ampicillin. To obtain pAB63 (Fig. 1b), a 3.4-kb PCR fragment containing uvrABbu and 504 bp 5′ to

its translational start site (possible promoter INCB024360 region) were amplified from B. burgdorferi 297 genomic DNA using primers AVB3 (containing a SacI restriction site) (Table 1) and AVB4 (containing a PstI restriction site) (Table 1), and ligated into the multiple cloning site of pKFSS1 (Frank et al., 2003) digested with SacI and PstI. To obtain pMS9 (Fig. 1b), the flaBBbu promoter and uvrABbu were amplified from B. burgdorferi 297 genomic DNA using primers FflaB/RflaB (containing SacI and KpnI restriction sites) (Table 1) and FuvrA/RurvA (containing KpnI and PstI restriction sites) (Table 1), respectively, and cloned into pKFSS1, first the flaBBbu promoter, then the ORF for uvrABbu, using the appropriate aminophylline restriction enzymes. Spirochetes grown to mid-logarithmic phase were electroporated with 5–20 μg of plasmid DNA (Samuels, 1995). Individual clones were obtained by serial dilution of aliquots taken from antibiotic-resistant cultures in complete BSK-H containing antibiotics.

Borrelia burgdorferi cells (1 × 105) (midlog phase) were inoculated into 0.5 mL of complete BSK-H containing 0.01, 0.1, 1, 5 or 10 μg of MMC (Sigma Chemical Co.) and cultured at 34 °C for 12–13 days, and spirochetes were counted in duplicate every 1–4 days by dark-field microscopy (Sicklinger et al., 2003). Bacteria were always kept in the dark during these experiments. Two independent experiments with each complementing plasmid were performed. Cells grown to a density of 3 × 107 cells mL−1 in complete BSK-H were harvested by centrifugation, resuspended in phosphate-buffered saline (PBS), pH 7.4, to 1 × 105 cells mL−1 and exposed to 800 or 1000 μJ cm−2 280-nm UV radiation (Spectrolinker XL-1000 UV crosslinker, Spectronics Corporation, Westbury, NY). Survival of cells after culture at 34 °C on semisolid BSK-H was determined at 14–18 days (Liveris et al., 2004). Borrelia burgdorferi not exposed to UV irradiation served as a control. Bacteria were always kept in the dark during these experiments.

Posted in Antibody | Leave a comment